Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 167,000 | 2,811,000 | 1,831,000 | 344,000 | 1,862,000 |
| Cost of Goods | 96,000 | 929,000 | 2,241,000 | 731,000 | 792,000 |
| Gross Profit | 71,000 | 1,882,000 | -410,000 | -387,000 | 1,070,000 |
| Operating Expenses | 1,337,000 | 1,876,000 | 1,602,000 | 1,480,000 | 1,436,000 |
| Operating Income | -1,266,000 | 6,000 | -2,012,000 | -1,867,000 | -366,000 |
| Other Income | 101,000 | 64,000 | 54,000 | 118,000 | 61,000 |
| Pre-tax Income | -1,165,000 | 70,000 | -1,958,000 | -1,749,000 | -305,000 |
| Income Tax | 10,000 | -147,000 | 1,672,000 | -369,000 | -384,000 |
| Net Income Continuous | -1,175,000 | 217,000 | -3,630,000 | -1,380,000 | 79,000 |
| Net Income | $-1,175,000 | $217,000 | $-3,630,000 | $-1,380,000 | $79,000 |
| EPS Basic Total Ops | -3.07 | 0.62 | -9.53 | -3.62 | 0.20 |
| EPS Basic Continuous Ops | -3.08 | 0.60 | -9.53 | -3.62 | 0.20 |
| EPS Diluted Total Ops | -3.07 | 0.63 | -9.53 | -3.62 | 0.19 |
| EPS Diluted Continuous Ops | -3.08 | 0.61 | -9.53 | -3.62 | 0.20 |
| EPS Diluted Before Non-Recurring Items | -3.07 | 0.55 | -1.39 | -3.62 | 0.19 |
| EBITDA(a) | $-1,257,000 | $188,000 | $-1,775,000 | $-1,787,000 | $-305,000 |